US EditionPublished • loading... • Updated
Alnylam Pharmaceuticals plans $250 Million expansion in Norton Massachusetts.
Summary by Intelligence360 News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Alnylam Pharmaceuticals plans $250 Million expansion in Norton Massachusetts.
Norton, Massachusetts — According to state and local development sources, Alnylam Pharmaceuticals plans to invest $250 Million to expand in Norton. The company plans to occupy the new space at 20 Commerce Way in Norton, on or about October 1, 2027. According to the company website Alnylam Pharmaceuticals is a leading biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics, an innovative class of medicines designed …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
